4th Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues, including Alzheimers disease drug development Drug Pricing Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) including priority review vouchers; HR 5378, Lower Costs, More Transparency Act; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring PBM (Pharmacy Benefit Manager) Accountability Act; improvements to the 340B drug discount program.

LobbyistCovered position, as disclosed
TRICIA BROOKS —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5378 (118th), S. 2973 (118th), S. 3430 (118th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, Part D Medicare Program, Part B Medicare Program; Drug Pricing; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for Alzheimers therapies; H.R. 5376, Inflation Reduction Act (PL 117-169) implementation; Center for Medicare and Medicaid Innovation (CMMI) Proposed Accelerated Approval Payment Policy.

LobbyistCovered position, as disclosed
TRICIA BROOKS —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Bills named: H.R. 5376 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.